BD Biosciences Clontech has recently introduced the BD Knockout inducible RNAi system.

According to the company, the system features inducible retroviral shRNA expression vectors, which are provided linearized and ready for ligation with a dsDNA oligonucleotide encoding an shRNA. It uses a modified tetracycline-controlled gene-expression system in which expression of an shRNA is induced when either tetracycline or doxycycline is added to the culture medium of an appropriately engineered cell.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.